Butterfly Network, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Joseph DeVivo
- Full Time Employees
- 220
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 1600 District Avenue Burlington MA United States of America 06437
- IPO Date
- Jul 13, 2020
- CIK
- 0001804176
- Website
- butterflynetwork.com
- Similar Companies
- Business
- Butterfly Network, Inc. (NYSE: BFLY) develops, manufactures, and commercializes handheld ultrasound-on-chip technology and related software solutions for point-of-care medical imaging. The company offers whole-body ultrasound probes including Butterfly iQ3, Butterfly iQ+, Butterfly iQ+ Bladder, and Butterfly iQ+ Vet; cloud-based software such as Compass for enterprise workflow integration, TeleGuidance, and AI-powered tools for image guidance and interpretation; educational platforms comprising in-app tutorials, ScanLab app, Butterfly Academy courses, and Butterfly Certified programs; and professional services for large-scale deployments. Butterfly Network, founded in 2011 and headquartered in Burlington, Massachusetts, operates primarily in the United States with international sales in regions including Europe, Asia, Africa, Australia, Indonesia, the Netherlands, and Belgium, targeting healthcare professionals, hospitals, clinics, veterinary practices, health systems, and medical education programs. In recent developments, the company launched the iQ3 ultrasound probe gaining traction in the U.S. and Europe with 55% product revenue growth; formed Octiv as a wholly-owned subsidiary to extend its Ultrasound-on-Chip technology into new sectors; expanded into new markets including Indonesia, the Netherlands, and Belgium driving 36% international revenue increase; initiated a Butterfly HomeCare pilot for AI-powered chronic care management with a Medicare Advantage provider; raised $75.6 million in post-IPO equity funding in January 2025 to enhance product lines and enter additional markets; and reported 5% revenue growth in Q3 2025 alongside advancements in AI tools for aortic valve imaging and gestational age assessment.
Butterfly Network's CEO Still Holds $51.3 Million in Stock After a 260% Run
What This Butterfly Network Filing Means Against $121 Million in Guidance and a Stock Up 260%
Butterfly Network to Report Second Quarter 2026 Financial Results on July 30, 2026
Jim Cramer Praises 'Miracle Worker' CEO, Says This Consumer Cyclical Stock Is ‘Too Hard To Own'
Butterfly Network Insider Sheds 399K Shares — This Stock May Be Ready to Take Flight
Butterfly Network Expands Handheld Ultrasound Reach in Brazil
BFLY's Embedded Partner Unveils Breakthrough in Brain Imaging Tech
Butterfly Network Expands its Handheld Ultrasound Availability into Brazil
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Are Medical Stocks Lagging Butterfly Network (BFLY) This Year?
Butterfly Network's Embedded™ Partner Aleph Neuro Unveils Stunning Brain Images
The Big 3: INTC, C, BFLY
Butterfly Network: Ambitious Silicon Technology
Butterfly Network (BFLY) Soars 55.9%: Is Further Upside Left in the Stock?
Butterfly Network Climbs On Midjourney Hype Despite FDA, Reimbursement Questions
Butterfly Network Provides Commentary on Midjourney Medical's Full Body Ultrasound Scanner Announcement
Butterfly Network Provides Commentary on Midjourney Medical's Full Body Ultrasound Scanner Announcement
Butterfly Network to Participate in TD Cowen's Medical Devices Emerging Growth Call Series on June 18, 2026
Butterfly Network to Participate in TD Cowen's Medical Devices Emerging Growth Call Series on June 18, 2026
Butterfly Network, Inc. (BFLY) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks Transcript